|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Current good manufacturing practice (cGMP) regulations are the means by which manufacturers, processors and packagers of drugs, medical devices, food and blood can ensure their products are safe, pure and effective. The objective is to prevent instances of contamination, mix-ups and errors by addressing issues such as record keeping, personnel qualifications and training, hygiene and housekeeping, cleanliness, equipment verification and process validation.
However, by its own admission, an organisation responsible for helping companies comply with GMP acknowledges that the regulations are as beneficial to commerce as they are to the consumer. On its website, the GMP Institute notes: "Compliance and performance are the goals of every food, drug, cosmetic, blood and medical device manufacturer. But they don't just happen. They are achieved when the FDA's GMP regulation becomes a lifestyle shared by everyone in the organisation. Compliance and performance occur only if facilities strive toward a proactive management system."
The ultimate aim of these regulations, which were originally championed by the US Food and Drug Administration (FDA) under the authority of the Federal Food, Drug and Cosmetic Act, is to protect consumers from purchasing products that are ineffective or dangerous. Legislation with identical objectives can be seen in the GMPs published in the EU. To enforce the widespread adoption of both sets of principles, failure to comply with GMP regulations is punishable by product recalls, seizures, fines and even jail sentences.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Paediatric Clinical Trials
19-20 January 2009, Copthorne Tara Hotel, London, UK
More info >>
|
|
 |
News and Press Releases |
 |
Financial Times hosts the Global Pharmaceutical and Biotechnology Conference
13th November 2008
More info >> |
|
|
